 The Pharmaceuticals Export Promotion Council of India (Pharmexcil) in association with Embassy of India at Romania recently organized a session on "India-Romania Pharma Business Opportunities” and B2B sessions to boost India-Romania Pharma trade.
During the session, Dr. Manoj Kumar Mohapatra, Ambassador of India to Romania, who represented both Romania and India shared his perspective of India Romania trade relations and significance of the pharmaceuticals as a thrust sector. He also shared the strengths of India pharma industry and its immense contribution to the healthcare expenditure of many countries.
During the session, Vlad Matei shared the guidelines of Medicinal Food Supplements in Romania and Gerald Flintoaca Filip, Consultant in the field of pharma in Romania spoke about the potential for generic medicines.
Raja Bhanu, director general, Pharmexcil presented the potential for India -Romania pharma trade and invited Romania to join iPHEX 2025 scheduled from 4th to 6th September, 2025 at Bharat Mandapam, New Delhi.
Around 15 companies from Romania and 125 companies from India side participated in B2B sessions coordinated by Murali Krishna, director, Pharmexcil.
The Romanian pharmaceutical industry is a thriving sector with significant growth in recent years, driven by factors like an aging population and increasing healthcare needs. Key players include both local and multinational companies. The industry encompasses production, distribution (including both wholesale and retail), and retail (pharmacies), with a strong emphasis on research and development.
The National Agency for Medicines and Medical Devices of Romania (NAMMDR) (Agenția Națională a Medicamentului și a Dispozitivelor Medicale) is the regulatory authority of Romania.
Government policies aim to reduce healthcare costs and improve access to essential medicines, often through promoting generic drug use.
India and Romania have a growing pharmaceutical trade relationship. Romania is actively seeking collaborations with Indian pharmaceutical companies for research, development, and licensing of drugs for the European market.
In 2024, India's exports of pharmaceutical products to Romania were valued at USD 33.45 million, according to Trading Economics.
Indian exports to Romania include medicaments, human or animal blood fractions, and other pharmaceutical goods.
The trade volume, though growing, still has potential for further expansion. Both countries are exploring new trade corridors and cooperation models to enhance their relationship.
|